In the present study, we investigated the expression patterns of Beclin 1 and Bcl-xL, by Western blotting and IHC, using fresh ovarian tissues and a TMA containing a series of benign, borderline and malignant epithelial ovarian tumors. Here, BCL2L1 is linked to cancer.